Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study descriptions for Thykamine and the introduction of new information regarding the PUR 0110 cream study, including its randomized trial structure and treatment concentrations.SummaryDifference34%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.